CALL - SPRINTER OPEN END - MERCK & CO. | Market Closed - Deutsche Boerse AG 14:03:28 2024-05-31 EDT | ||
| 2.55 EUR | -7.94% |
|
| 1 month | -17.74% | ||
| 3 months | -12.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 2.55 | -7.94% |
| 24-05-30 | 2.77 | +5.32% |
| 24-05-29 | 2.63 | +0.38% |
| 24-05-28 | 2.62 | -10.27% |
| 24-05-27 | 2.92 | -1.68% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 02:03 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Vontobel
|
| WKN | VM5434 |
| ISIN | DE000VM54344 |
| Date issued | 2023-11-29 |
| Strike | 98.09 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.55 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.33 € |
|---|---|
| Lowest since issue | 0.61 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Certificates
- Certificat
